retatrutide while pregnant Phase III study demonstrates 30% weight loss Abdominal swelling Meal Count:30 Meals Did you know that

retatrutide while pregnant Phase III study demonstrates 30% weight loss Abdominal swelling Meal Count:30 Meals Did you know that

Did you know that GLP-1 medications can be used to reduce the risk of heart attack and stroke? Cardiologist Rohan Penmetcha, DO, shares how recent studies show that GLP-1 medications can be

Because retatrutide activates three receptor types simultaneously, its gastrointestinal side effect profile can be more intense than single or dual agonists

Abdominal swelling

Meal Count:30 Meals

Currently, GLP-1 receptor agonists should only be used for FDA-approved indications such as type 2 diabetes or obesity